<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="67015">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01752439</url>
  </required_header>
  <id_info>
    <org_study_id>tDCSCMMOH1</org_study_id>
    <nct_id>NCT01752439</nct_id>
  </id_info>
  <brief_title>Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache</brief_title>
  <official_title>Randomized Double-Blind Sham-Controlled Study of the Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Armando Perrotta, MD, PhD</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mediterranean Neurological Institute</source>
  <oversight_info>
    <authority>Italy: National Monitoring Centre for Clinical Trials - Ministry of Health</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of the study is to evaluate the efficacy of the transcranial direct current
      stimulation of the primary motor cortex (M1) in patients affected by refractory chronic
      migraine (coded as 1.5.1 in the international headache classification 2nd edition, 2004) and
      medication-overuse headache (coded as 8.1) with migraine as primary headache.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>February 2013</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in headache days per months</measure>
    <time_frame>at 30, 60 and 90 days after the treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in drugs intake per months</measure>
    <time_frame>at 30, 60 and 90 days after treatment</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in mean pain intensity score per months</measure>
    <time_frame>at 30, 60 and 90 days after treatment</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Chronic Migraine</condition>
  <condition>Medication Overuse Headache</condition>
  <arm_group>
    <arm_group_label>Anodal transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Anodal transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham transcranial direct current stimulation</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Sham transcranial direct current stimulation</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Anodal transcranial direct current stimulation</intervention_name>
    <arm_group_label>Anodal transcranial direct current stimulation</arm_group_label>
    <other_name>Transcranial direct current stimulator HDCstim, Newronika s.r.l., Milan, Italy</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Sham transcranial direct current stimulation</intervention_name>
    <arm_group_label>Sham transcranial direct current stimulation</arm_group_label>
    <other_name>Transcranial direct current stimulator HDCstim, Newronika s.r.l., Milan, Italy</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Chronic MIgraine or Medication Overuse Headache according to the diagnostic criteria
             set out in the 2nd edition of the International Classification of Headache Disorders
             refractory to treatment according to the Refractory Headache Special Interest Section
             of the American Headache Society (Schulman et al., 2008)

        Exclusion Criteria:

          -  Other primary or secondary headaches.

          -  Any serious systemic or neurological disease or psychiatric disorder.

          -  Pregnancy or breastfeeding

          -  Previous or current use of other or similar devices for pain control

          -  Heart conduction and rhythm disorders

          -  Cranial surgery

          -  Other pain conditions, accordingly with current guidelines
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 14, 2012</lastchanged_date>
  <firstreceived_date>December 11, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Mediterranean Neurological Institute</investigator_affiliation>
    <investigator_full_name>Dr Armando Perrotta, MD, PhD</investigator_full_name>
    <investigator_title>MD, PhD</investigator_title>
  </responsible_party>
  <keyword>Chronic Migraine</keyword>
  <keyword>Medication Overuse Headache</keyword>
  <keyword>Refractory</keyword>
  <keyword>transcranial direct current stimulation</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Headache</mesh_term>
    <mesh_term>Migraine Disorders</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
